Literature DB >> 6104035

Immune-complex glomerulopathy in patients treated with captopril.

S J Hoorntje, C G Kallenberg, J J Weening, A J Donker, T H The, P J Hoedemaeker.   

Abstract

Renal biopsies were performed on 13 patients treated with captopril. In 4 patients findings indicated an early stage of membranous glomerulopathy (MGP). In the other patients electron microscopy showed scanty small subepithelial deposits and immunofluorescence revealed a patchy granular pattern along the glomerular basement membrane. One of the 4 patients with MGP presented with nephrotic syndrome and another with serum-sickness-like syndrome. None of the other patients, including 2 with MGP, had proteinuria or deterioration of renal function. Thus captopril may be associated with the development of immune-complex glomerulopathy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104035     DOI: 10.1016/s0140-6736(80)91677-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  24 in total

Review 1.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

Review 2.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

Review 3.  ACE inhibitors and the kidney. A risk-benefit assessment.

Authors:  G Navis; H J Faber; D de Zeeuw; P E de Jong
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

4.  A rat model of captopril immunogenicity.

Authors:  A L Foster; J W Coleman
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

5.  Inhibitors of angiotensin I converting enzyme for treating hypertension.

Authors: 
Journal:  Br Med J       Date:  1980-09-06

6.  Angiotensin converting enzyme inhibition: a new therapeutic modality.

Authors:  H Gavras; F Charocopos; H Brunner; I Gavras
Journal:  Bull N Y Acad Med       Date:  1981-05

Review 7.  Experimental mercury-induced glomerulonephritis.

Authors:  L Pelletier; F Hirsch; J Rossert; E Druet; P Druet
Journal:  Springer Semin Immunopathol       Date:  1987

8.  How adverse drug reactions can play a role in innovative drug research.

Authors:  F Rikken; R Vos
Journal:  Pharm World Sci       Date:  1995-11-24

9.  Long-term effects of captopril on renal function in hypertensive patients.

Authors:  Z Glück; C Beretta-Piccoli; F C Reubi
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Drug-specific antibodies in patients receiving captopril.

Authors:  J W Coleman; J H Yeung; D H Roberts; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.